AR and glioblastoma: Then, we performed a pathway analysis of these genes using the IPA tool and we found the AR signaling pathway, whose aberrant activation promotes GBM progression and therapy resistance [24], as one of the top enriched pathways regarding TMZ response (Fig. 3A).